Try a new search

Format these results:

Searched for:

in-biosketch:true

person:moreia01

Total Results:

309


Bacille Calmette-Guerin: efficacy and immunity

Chapter by: Moreira AL
in: Tuberculosis by Ron WN; Garay SM [Eds]
Philadelphia : Lippincott Williams & Wilkins, 2004
pp. 875-884
ISBN: 0781736781
CID: 3987

Determinants of response to interleukin-10 receptor blockade immunotherapy in experimental visceral leishmaniasis

Murray, Henry W; Moreira, Andre L; Lu, Cristina M; DeVecchio, Jennifer L; Matsuhashi, Maki; Ma, Xiaojing; Heinzel, Frederick P
In established Leishmania donovani visceral infection in normal mice, anti-interleukin (IL)-10 receptor (IL-10R) monoclonal antibody (MAb) treatment induced intracellular parasite killing within liver macrophages. IL-10R blockade maintained IL-12 protein 40, markedly increased interferon (IFN)-gamma serum levels, and enhanced tissue inducible nitric oxide synthase (iNOS) expression and granuloma assembly. Optimal MAb-induced killing, including synergism with antimony chemotherapy, required endogenous IL-12 and/or IFN-gamma and at least one IFN-gamma-regulated macrophage mechanism-iNOS or phagocyte oxidase. However, in IFN-gamma knockout mice, anti-IL-10R also induced both granuloma formation and leishmanistatic activity. As judged by IL-10R blockade, endogenous IL-10 primarily regulates killing in L. donovani infection by suppressing production of and responses to the Th1 cell-type cytokines, IL-12, and IFN-gamma. However, because anti-IL-10R also released IFN-gamma-independent effects, IL-10 appears to act more broadly and suppresses multiple antileishmanial mechanisms.
PMID: 12870129
ISSN: 0022-1899
CID: 650462

Multinodular thyroid gland: Is there a role for aspirating more than one nodule? [Meeting Abstract]

Oweity, T; Waisman, J; Moreira, A; Yee, J; Cangiarella, J
ISI:000180720100495
ISSN: 0893-3952
CID: 38522

Aspiration biopsy of mammary lesions with abundant extracellular mucinous material. Review of 43 cases with surgical follow-up

Ventura, Karyna; Cangiarella, Joan; Lee, Irene; Moreira, Andre; Waisman, Jerry; Simsir, Aylin
We reviewed 43 fine-needle aspiration biopsy (FNAB) smears with abundant extracellular mucinous material to determine whether accurate classification of mucinous lesions is achievable on FN 26 had carcinoma (pure colloid carcinoma [CCA], 23; mixed CCA/invasive ductal carcinoma [IDC], 3); 17 had benign lesions on follow-up (benign MLL, 6; fibrocystic change [FCC], 6; myxoid fibroadenoma [MFA], 5). All carcinomas were identified correctly as malignant on FNAB. The initial cytologic diagnoses in benign cases were benign in 8, atypical in 8, and 'suspicious' for carcinoma in 1. CCAs were moderate to markedly cellular with mild to moderate atypia and lacked oval bare nuclei. Marked nuclear atypia was confined predominantly to cases with mixed CCA/IDC. A distinct feature of CCA was thin-walled capillaries. FCCs and benign MLLs had overlapping cytologic features and showed variable cellularity and no or mild atypia. MFAs were markedly cellular with dyscohesion and variable atypia; stromal fragments and oval bare nuclei were present in every case. Mucinous lesions can be divided into 2 categories by FN those that are adenocarcinomas and those that are not. CCAs have distinctive features that allow a definitive diagnosis on FNAB. Unnecessary surgery can be avoided in MFA by careful evaluation of smear characteristics. Cytologic features of FCC and MLL overlap. Owing to the documented association of MLL with carcinoma, we recommend that lesions that cannot be classified definitively as adenocarcinoma or MFA be considered for conservative excision, even in the absence of atypia
PMID: 12931549
ISSN: 0002-9173
CID: 39101

Mycobacterium tuberculosis growth at the cavity surface: a microenvironment with failed immunity

Kaplan, Gilla; Post, Frank A; Moreira, Andre L; Wainwright, Helen; Kreiswirth, Barry N; Tanverdi, Melike; Mathema, Barun; Ramaswamy, Srinivas V; Walther, Gabi; Steyn, Lafras M; Barry, Clifton E 3rd; Bekker, Linda-Gail
Protective immunity against pulmonary tuberculosis (TB) is characterized by the formation in the lungs of granulomas consisting of macrophages and activated T cells producing tumor necrosis factor alpha and gamma interferon, both required for the activation of the phagocytes. In 90% of immunocompetent humans, this response controls the infection. To understand why immunity fails in the other 10%, we studied the lungs of six patients who underwent surgery for incurable TB. Histologic examination of different lung lesions revealed heterogeneous morphology and distribution of acid-fast bacilli; only at the surface of cavities, i.e., in granulomas with a patent connection to the airways, were there numerous bacilli. The mutation profile of the isolates suggested that a single founder strain of Mycobacterium tuberculosis may undergo genetic changes during treatment, leading to acquisition of additional drug resistance independently in discrete physical locales. Additional drug resistance was preferentially observed at the cavity surface. Cytokine gene expression revealed that failure to control the bacilli was not associated with a generalized suppression of cellular immunity, since cytokine mRNA was up regulated in all lesions tested. Rather, a selective absence of CD4(+) and CD8(+) T cells was noted at the luminal surface of the cavity, preventing direct T-cell-macrophage interactions at this site, probably allowing luminal phagocytes to remain permissive for bacillary growth. In contrast, in the perinecrotic zone of the granulomas, the two cell types colocalized and bacillary numbers were substantially lower, suggesting that in this microenvironment an efficient bacteriostatic or bactericidal phagocyte population was generated
PMCID:308931
PMID: 14638800
ISSN: 0019-9567
CID: 112880

Mammary lesions with abundant extracellular mucin: Is accurate classification possible by fine needle aspiration biopsy? [Meeting Abstract]

Ventura, K; Lee, I; Waisman, J; Moreira, A; Cangiarella, J; Simsir, A
ISI:000173388900383
ISSN: 0893-3952
CID: 27534

Mammary lesions with abundant extracellular mucin: Is accurate classification possible by fine needle aspiration biopsy? [Meeting Abstract]

Ventura, K; Lee, I; Waisman, J; Moreira, A; Cangiarella, J; Simsir, A
ISI:000173379700379
ISSN: 0023-6837
CID: 27543

Metastatic "borderline" papillary ovarian tumor in an intramammary lymph node [Case Report]

Moreira, Andre L; Yao, Jorge; Waisman, Jerry; Cangiarella, Joan F
PMID: 12199761
ISSN: 1075-122x
CID: 34588

Interleukin-10 (IL-10) in experimental visceral leishmaniasis and IL-10 receptor blockade as immunotherapy

Murray, Henry W; Lu, Christina M; Mauze, Smita; Freeman, Sherry; Moreira, Andre L; Kaplan, Gilla; Coffman, Robert L
Interleukin-10 (IL-10) is thought to promote intracellular infection, including human visceral leishmaniasis, by disabling Th1 cell-type responses and/or deactivating parasitized tissue macrophages. To develop a rationale for IL-10 inhibition as treatment in visceral infection, Th1 cytokine-driven responses were characterized in Leishmania donovani-infected BALB/c mice in which IL-10 was absent or overexpressed or its receptor (IL-10R) was blockaded. IL-10 knockout and normal mice treated prophylactically with anti-IL-10R demonstrated accelerated granuloma assembly and rapid parasite killing without untoward tissue inflammation; IL-12 and gamma interferon mRNA expression, inducible nitric oxide synthase reactivity, and responsiveness to antimony chemotherapy were also enhanced in knockout mice. In IL-10 transgenic mice, parasite replication was unrestrained, and except for antimony responsiveness, measured Th1 cell-dependent events were all initially impaired. Despite subsequent granuloma assembly, high-level infection persisted, and antimony-treated transgenic mice also relapsed. In normal mice with established infection, anti-IL-10R treatment was remarkably active, inducing near-cure by itself and synergism with antimony. IL-10's deactivating effects regulate outcome in experimental visceral leishmaniasis, and IL-10R blockade represents a potential immuno- and/or immunochemotherapeutic approach in this infection
PMCID:130311
PMID: 12379707
ISSN: 0019-9567
CID: 35025

Local nerve damage in leprosy does not lead to an impaired cellular immune response or decreased wound healing in the skin

Siddiqui, M Ruby; Moreira, Andre L; Negesse, Yohannes; Taye, Genet A; Hanekom, Willem A; Haslett, Patrick A J; Britton, Sven; Kaplan, Gilla
This study investigated whether peripheral nerve damage in patients with leprosy impairs local cellular immune responses, thereby reducing wound healing and leading to chronic skin ulceration. Anesthetic and contralateral sensitive skin sites in 42 patients with leprosy were compared for delayed-type hypersensitivity responses to purified protein derivative (PPD) of tuberculin. Leukocyte recruitment, epidermal activation, keratinocyte proliferation, and rates of wound healing after skin biopsy were compared. No significant differences in PPD-induced induration, epidermal activation and thickening or numbers of total T cells, CD8+ T cells, CD1a+ Langerhans cells, and proliferating Ki67+ keratinocytes were observed between anesthetic and sensitive skin sites. Similarly, rates of wound healing over 5 days after skin biopsy did not differ significantly. Thus, local leprosy-associated anesthesia does not appear to contribute to local immune compromise or impaired wound healing. Rather, chronic cutaneous ulceration in leprosy most likely results from repeated trauma associated with loss of sensation
PMID: 12134264
ISSN: 0022-1899
CID: 35026